Trial of a Smartphone Application to Improve Medication Adherence among Patients with Cancer
Smartphone App for Cancer Medication Adherence
Sponsor: Susan G. Komen
Enrolling: Male and Female Patients
IRB Number: AAAS5950
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: Many patients with metastatic cancer experience frustration with the large number and complex scheduling of their medications. This study will help us find out how much pill burden exists in patients with advanced cancer, and how a smartphone app can help patients take their medications as their providers prescribe. Results of this study may help us figure out the best way to help patients manage their medications in the future. Cancers include bladder cancer, brain and spinal tumors, breast cancer, colon and rectal cancer, esophageal cancer, gynecologic cancers, head and neck/oral cancer, kidney cancer, leukemia, liver cancer, lung cancer, lymphoma, skin cancers, multiple myeloma, pancreatic cancer, prostate cancer, sarcomas, stomach cancer, testicular cancer, and thyroid cancer.
Investigator
Melissa Accordino, MD
Do You Qualify?
Do you have advanced or metastatic cancer, or a hematologic malignancy? Yes No
Are you taking, or planning to take at least one oral anti-cancer drug? Yes No
Do you have access to a mobile phone or tablet that can download Apple or Android applications? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Research Nurse Navigator
cancerclinicaltrials@cumc.columbia.edu
212-342-5162